Delivery Order SPE2DB22D2009-SPE2DB25FM1BU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,948.02 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,231.35 for WIXELA 250-50 INHUB 60S, a pharmaceutical product, with a completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child task order under AmerisourceBergen Drug Corp's larger contract vehicle with the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for WIXELA 250-50 inhalation powder (60-unit package) with a ceiling value of $1,733.01. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $1,290.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for WIXELA 250-50 INHUB 60S, a pharmaceutical product to be delivered to Conshohocken, Pennsylvania by August 12, 2025. This is a non-set-aside, competitively awarded contract issued as a child delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.86 to AmerisourceBergen Drug Corp for WIXELA 100-50 inhalation powder, a combination asthma and COPD medication. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,349.80 to AmerisourceBergen Drug Corp for WIXELA 500-50 INHUB 60S, a pharmaceutical product, with an ultimate completion date of August 1, 2025. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This is a $1,327.64 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract is for the supply of the pharmaceutical product WIXELA 250-50 INHUB 60S, with a performance period extending to July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of WIXELA 500-50 INHUB 60S pharmaceutical products, valued at $1,362.00 with a completion date of September 12, 2024. This order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the WIXELA 250-50 INHUB 60S medication. The $1,470.90 Firm Fixed Price contract has a performance period extending to May 12, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which enables the company to provide a wide range of pharmaceutical products...
- This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,080.48, is for the delivery of WIXELA 500-50 INHUB 60S pharmaceutical products. The contract has an ultimate completion date of July 2, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1BUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,148.66 to AmerisourceBergen Drug Corp for WIXELA 250-50 INHUB 60S on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. WIXELA is a combination inhaled medication used in respiratory disease treatment, representing a typical pharmaceutical product delivery under the company's federal contract portfolio. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems and other federal customers worldwide. AmerisourceBergen Drug Corp's extensive federal contracting history demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through competitive processes and deliver products across multiple therapeutic domains in support of military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/22/25 |